Evidence map›Paper›PMID 40062768›Full record

ArticleMicrobiology spectrum2025

Application of versatile reverse genetics system for feline coronavirus.

Izumi Kida, Tomokazu Tamura, Yudai Kuroda, Takasuke Fukuhara, Ken Maeda, Keita Matsuno

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Izumi KidaDivision of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-6312-1454
Tomokazu TamuraDepartment of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0003-1395-6610
Yudai KurodaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Takasuke FukuharaDepartment of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Ken MaedaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Keita MatsunoDivision of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-4205-6526

Funding

Hokuto Foundation for BioscienceJapan Agency for Medical Research and Development JP22gm1610008Japan Agency for Medical Research and Development JP23jf0126002Japan Science and Technology Agency JPMJSP2119Japan Society for the Promotion of Science 21H02736Japan Society for the Promotion of Science JP23K20041Northern Advancement Center for Science and Technology T-1-26
6 · The paper itself

Abstract

Feline infectious peritonitis (FIP) is a fatal disease caused by feline coronavirus (FCoV). Although multiple gene mutations in FCoV likely account for FIP pathogenesis, molecular studies for FCoV have been limited due to the lack of a suitable reverse genetics system. In the present study, we established a rapid PCR-based system to generate recombinant FCoV using the circular polymerase extension reaction (CPER) method for both serotype 1 and 2 viruses. Recombinant FCoV was successfully rescued at sufficient titers to propagate the progeny viruses with high sequence accuracy. The growth kinetics of recombinant FCoV were comparable to those of the parental viruses. We successfully generated recombinants harboring the spike gene from a different FCoV strain or a reporter HiBiT tag using the CPER method. The chimeric virus demonstrated similar characteristics with the parental virus of the spike gene. The reporter tag stably expressed after five serial passages in the susceptible cells, and the reporter virus could be applied to evaluate the sensitivity of antiviral inhibitors using the luciferase assay system to detect HiBiT tag. Taken together, our versatile reverse genetics system for FCoV shown herein is a robust tool to characterize viral genes even without virus isolation and to investigate the molecular mechanisms of the proliferation and pathogenicity of FCoV. IMPORTANCE: Feline infectious peritonitis is a highly fatal disease in cats caused by feline coronavirus variants that can infect systemically. Due to the lack of a versatile toolbox for manipulating the feline coronavirus genome, an efficient method is urgently needed to study the virus proteins responsible for the severe disease. Herein, we established a rapid reverse genetics system for the virus and demonstrated the capability of the recombinant viruses to be introduced with desired modifications or reporter genes without any negative impacts on virus characteristics in cell culture. Recombinant viruses are also useful to evaluate antiviral efficacy. Overall, our system can be a promising tool to reveal the molecular mechanisms of the viral life cycle of feline coronavirus and disease progression of feline infectious peritonitis.

Indexed as

Coronavirus, FelineFeline Infectious PeritonitisReverse GeneticsAnimalsAntiviral AgentsCatsCell LineGenes, ReporterGenome, ViralSpike Glycoprotein, CoronavirusVirus ReplicationAntiviral AgentsSpike Glycoprotein, Coronavirusfeline coronavirusfeline infectious peritonitisreverse genetics

Identifiers

PMID40062768
PMCPMC11960445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.